#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Breast cancer Hyperinsulinism Chronic granulomatous disease Squamous cell carcinoma of the vulva Gastroenteropancreatic neuroendocrine tumour disease Acquired ATTR amyloidosis Infantile spasms Central nervous system neoplasm Autologous haematopoietic stem cell transplant Desmoplastic small round cell tumour Transplant rejection Short stature homeobox gene mutation Thromboangiitis obliterans Congenital ectodermal dysplasia Bronchopulmonary aspergillosis More trials…

    Learn about Rare Diseases

    Osteosarcoma metastatic – Diagnostics Chronic granulomatous disease – Life with Disease Langerhans’ cell histiocytosis – Trials in Disease Lysosomal storage disorder – Life with Disease Arterial tortuosity syndrome – Basic Information Mast cell activation syndrome – Basic Information Primary immunodeficiency syndrome – Life with Disease Niemann-Pick disease – Basic Information Myxofibrosarcoma – Trials in Disease Focal segmental glomerulosclerosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Triglycerides, Medium Chain L-Histidine Urea MORPHINE Valbenazine Ditosylate Tioguanine Lenalidomide Nadunolimab AAV9-CTNT-COBAG3 Naproxen Sodium Lecanemab Lonvoguran Glasdegib Icosapent Ethyl [18F] CANAGLIFLOZIN Dexrazoxane Hydrochloride Festuca Rubra Pollen Morf-057 Isis 696844 Ads-013 More therapies…

    Learn about Your Condition

    Takayasu's arteritis Dupuytren's contracture Systemic sclerosis pulmonary Cold urticaria Viral infection Glioma Lichen planus Small fibre neuropathy EGFR gene mutation Skin candida Diabetes mellitus Arrhythmia supraventricular Neck pain Tardive dyskinesia Naevoid melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2al Baesgdbet Dv Sjjdjy Moalkmzhslc Bv 1mwg Mwhksrydpn 1davkm Flowef

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Alpelisib
    • Fulvestrant
    Belgium Bulgaria Czechia Denmark Finland France +10

  • Study on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Sorafenib
    • Durvalumab
    • Infliximab
    France Germany Italy Spain

  • Study on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Enfortumab Vedotin
    • Durvalumab
    • Infliximab
    Austria France Germany Greece Italy The Netherlands +3

  • Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Golcadomide
    • Apixaban
    • Betamethasone Sodium Phosphate
    Austria Bulgaria Czechia Denmark Finland France +11

  • Study Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Fludarabine Phosphate Ph. Eur.
    • Idecabtagene Vicleucel
    • Cyclophosphamide Monohydrate
    Austria Belgium Czechia Denmark France Germany +6

  • Study of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Palonosetron
    • Adagrasib
    • Carboplatin
    France Greece Hungary Italy Poland Spain

  • Study on the Effects of Samuraciclib and Elacestrant for Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Samuraciclib
    • Elacestrant
    France Spain

  • Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Marginal zone lymphoma refractory
    • Marginal zone lymphoma
    • Follicular lymphoma
    Investigated Drugs:
    • Odronextamab
    • Lenalidomide
    • Rituximab
    Austria Belgium Czechia France Germany Italy +2

  • Study on the Safety and Effectiveness of BLU-222 Alone and with Drug Combination for Patients with Advanced Solid Tumors, Including Breast and Ovarian Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Blu-222
    • Carboplatin
    • Fulvestrant
    Belgium France Italy Spain

  • Study of BMS-986449 and Nivolumab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Bms-986449-03
    • Nivolumab
    Belgium France Italy The Netherlands Spain
Previous Page
1 … 35 36 37 38 39 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!